-3.21% for UiPath stock as overbought readings fail to trigger a bounce

Traders Union
All News
Financial News
UiPath drops 3.21% to $12.05 today

Highlights

UiPath strengthened its partnership with Deloitte and Microsoft, expanding AI-driven ERP automation and boosting platform security integration.
The company reported first full-year GAAP profitability with $1.61 billion in revenue, $282.33 million net income, and completed a $1 billion share buyback alongside launching a new $500 million repurchase program.
Technical signals indicate short-term buyer strength but rising bearish pressure, with the stock likely trading between $11.00 and $12.80 and downside risk prevailing.

Profitability milestone and buyback contrast with sustained selling pressure

On March 12, 2026, UiPath expanded its partnership with Deloitte by introducing the Agentic ERP solution, which utilizes UiPath Maestro to modernize enterprise ERP systems through AI-driven process automation. The company has also launched a new security automation feature in cooperation with Microsoft, aiming to integrate its automation platform with Microsoft’s security suite for enhanced threat detection and response. Earlier in March, UiPath reported fourth-quarter revenue of $481.11 million and a full-year total of $1.61 billion, marking its first full year of GAAP profitability with net income of $282.33 million. A $1 billion share buyback was completed alongside a new $500 million repurchase program, though price action has remained under broader selling pressure.

Overbought oscillators and fresh selling signal bearish momentum on weak ADX

Technically, the Ichimoku Kijun level at $11.41 acts as immediate support below the current price. Momentum signals on the D1 timeframe are mixed: MACD reflects strong selling pressure, and the ADX is weak with a sell bias, indicating a mild bearish trend. RSI is in neutral-bullish territory, but both Stoch RSI and CCI show overbought conditions, flagging potential exhaustion. BBP is strongly positive (overbought), suggesting intraday buyer dominance, while the Awesome Oscillator remains neutral, providing little confirmation to the overall trend. With PATH closing near the session low and no gap at the open, moderate volatility and continued intraday selling are evident. The sharp divergence between overbought oscillators and persistent selling highlights short-term buyer strength giving way to broader bearish sentiment.

Further downside likely as odds of rebound diminish near support

In the short term, PATH is expected to fluctuate within a typical volatility band between $11.00 and $12.80 over the next five trading days. The probability of a price increase is low (less than 20%), making further downside more likely as the stock hovers near immediate support at $11.41, with resistance around $12.86. A move above $12.86 could trigger a further rally but may encounter significant resistance from higher moving averages. Conversely, a drop below $11.41 would likely expose the stock to additional declines if overbought conditions unwind and seller dominance persists.

Viktoras Karapetjanc, expert at Traders Union, sees UiPath’s continued innovation and its landmark GAAP profitability as strong fundamental positives. He believes broader market sentiment and technical resistance still weigh heavily in the short term, but institutional moves like share buybacks add conviction for medium-term stability. Karapetjanc notes that with support at $11.41 holding, further downside risk remains, yet momentum from recent enterprise partnerships could lift confidence if selling exhausts. "While bears are in control for now, I expect resilience from UiPath as new strategic partnerships and profitability start to reshape investor sentiment."

Earlier, analysts noted that UiPath’s short-term momentum was fading amid continued volatility and diverging technical signals. The latest data reinforce this caution, as persistent intraday selling and overbought oscillators suggest traders should closely monitor for a potential downside break below current support.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.